Skabi-Rid Permethrin 5% lotion

  • Treatment of Choice Worldwide for more than 10 years
  • Listed on WHO Essential Drug List
  • Permethrin 5% is FDA Approved
  • Reg No: A40/13.2/0756
  • Nappi Code: 713148-001
  • Barcode: 6009665060002
Skabi-Rid was developed out of need for a new, safer, more effective and simpler treatment for scabies. This condition affects more than 300 million people worldwide every year.

Compliance in treating is essential as incomplete treatment leads to resistance, spreading of the disease and further morbidity. This application cures scabies with a single application. The formulation was developed by the Research Institute for Industrial Pharmacy, Potchefstroom.

Active Ingredient:

Skabi-Rid contains permethrin 5% (5g in 100g). Permethrin belongs to a group of toxins called the pyrethroids, synthetic derivatives of pyrethrins designed to be stable in ultraviolet light, whilst retaining the potent insecticidal properties.

Pyrethrins originate from the chrysanthemum genus of plants originally from China; these plants were cultivated in China as a flowering herb as far back as the 15th century BC. About 200 years ago people living in central Asia discovered that dried, crushed flowers of certain chrysanthemums were toxic to insects.

Chrysanthemum Flowers


No more scratching around for first line treatment of Scabies

Better Efficacy
Proven to be more effective than
  • Oral ivermectin
  • Topical crotamiton
  • Topical lindane
As effective as benzyl benzoate
Efficacy in resistant lice infestation

Better Compliance
  • One single application
Best safety profile of all scabies treatment
  • Less irritation than benzyl benzoate & lindane
  • Treatment of choice for pregnant women in the US and UK
    CDC 1998 Guidelines for treatment of sexually transmitted diseases. MMWR 1998;47:1116.
    Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). National guideline for the management of scabies. Sex Transm Inf 1999;75 (Suppl):S767
    The risk of foetal toxicity following maternal application of permethrin is likely to be no greater than that for the general population
    (Drugs.com (sources include Micromedex™, Wolters Kluwer™))
  • First line treatment for scabies in AIDS patients
  • Treatment of choice for lactating women

Tomar

© 2016 Skabi-Rid® All rights reserved. Skabi-Rid is a registered trademark of TomarMed (Pty) Ltd
Email: info@skabi-rid.com

  Website by S² Web Solutions